Pinealon
Also known as: EDR Peptide
A tripeptide bioregulator for brain and pineal gland function.
Overview
Pinealon is a synthetic tripeptide bioregulator developed in Russia, designed to support pineal gland and brain function. It belongs to the Khavinson peptide family of bioregulators.
Mechanism of Action
Gene regulatory effects on brain tissue. May support melatonin synthesis and circadian rhythm. Proposed epigenetic modulation of neuronal genes.
Pharmacokinetics
Small size allows CNS penetration. Can be administered orally, sublingually, or via injection.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Oral
10-20 mg
1-2x daily
10-30 days
Sublingual for better absorption
Injection
1-2 mg
Once daily
10 days
Intensive protocol
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Improved cognitive function in elderly subjects in Russian studies
- 2Normalized circadian rhythm markers
- 3Neuroprotective effects in cell culture
- 4Gene expression modulation in brain tissue
Side Effects & Contraindications
Reported Side Effects
- Generally well-tolerated
Contraindications
- Unknown
Safety Considerations
Generally well-tolerated. Limited Western clinical data.
Storage Requirements
Store at room temperature or 2-8C
Scientific References
- 1